Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Combining α-blockers and Finasteride is useful for treating small prostate enlargement.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Edar signaling is crucial for controlling hair growth and regression.

Graves' disease mainly causes hyperthyroidism in children, especially girls aged 10-14, with treatment options including medication, radioactive iodine, and surgery.

Chronic pelvic pain in men is common, but its cause is unknown and treatments are often ineffective.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.